CONTACT: Jill S. Abrams, Assistant Attorney General, (802) 828-1106
Attorney General TJ Donovan urges Vermont residents to file claims on a $125 million multistate settlement that provides $35 million to consumers who paid for the brand-name drug Provigil or generic modafinil from June 24, 2006, to March 31, 2012. At the States’ request, the court extended the time to file claims on the settlement to June 25, 2017.
Provigil, which includes the active ingredient modafinil, is approved by the federal Food and Drug Administration (FDA) to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea and shift work disorder.
In August 2016, state attorneys general in Vermont and 47 other states announced the settlement with biopharmaceutical company Cephalon and its affiliated companies, including Teva Pharmaceutical Industries, Teva Pharmaceuticals USA and Barr Laboratories, that resolved allegations that the companies engaged in unlawful “pay-for-delay” anticompetitive conduct involving the patent exclusivity for Provigil.
The settlement included $35 million to compensate eligible consumers who may have been harmed by the alleged conduct. While the claims period has been advertised for several months, many consumers may not realize that the claims period will close.
For more information or to obtain a claim form, visit www.StateAGProvigilSettlement.com or call 1-877-236-1413.
Last modified: February 13, 2018